All

Results: 34297-34308 of 57776

Suzano reports Adjusted EBITDA of R$6.3 billion in the second quarter of 2024

Unity Strengthens Advertising Leadership Team with MoPub and MAX founder Jim Payne Joining the Company

Five9 Announces an End-to-End AI Suite and New Approach to Transform Enterprise CX

Five9 to Acquire Acqueon to Expand its Industry-Leading Omnichannel Outreach and Journey Orchestration for the Enterprise

Innodata Reports Second Quarter 2024 Results; Record 66% Revenue Growth Year-Over-Year

Atlantica Holds Shareholders’ Meetings to Approve its Acquisition by Energy Capital Partners and Co-Investors

Prothena Reports Second Quarter 2024 Financial Results and Business Highlights

Issuer Direct Reports Second Quarter 2024 Results

Bifidobacterium infantis M-63 is a unique probiotic strain of human-residential bifidobacteria (HRB) – bifidobacteria that naturally reside in the human gut – and is renowned for its ability to utilize human milk oligosaccharides (HMO) found in breast milk, significantly improving the intestinal environment of healthy full-term infants. (Graphic: Business Wire)

Morinaga Milk Obtains the Registration of "New Food Ingredient" in China for use of its Probiotic Bifidobacterium infantis M-63 in Infant Foods

PR Newswire associated0

HTX Ventures Invests in Nexio to Enhance The Bitcoin Ecosystem

Uzum boosts net income 50% in 1H 2024, prepares for Series B funding round

CoreView Expands EMEA Operations with Key Appointments and Strategic Partnerships